Dingtong(SH:688668)2023-04-18 16:00Financial Performance - The company's operating revenue for Q1 2023 was ¥161,984,478.66, representing a decrease of 8.18% compared to the same period last year[5] - The net profit attributable to shareholders was ¥33,217,709.99, an increase of 3.06% year-on-year[5] - The net profit after deducting non-recurring gains and losses was ¥30,437,577.51, showing a decrease of 2.75% compared to the previous year[5] - Total revenue for Q1 2023 was ¥161,984,478.66, a decrease of 8.5% compared to ¥176,410,036.28 in Q1 2022[19] - Operating profit for Q1 2023 was ¥36,722,941.82, slightly down from ¥37,003,121.48 in Q1 2022, reflecting a decrease of 0.8%[20] - Net profit for Q1 2023 reached ¥33,217,709.99, an increase of 3.1% from ¥32,232,358.15 in Q1 2022[20] - Basic and diluted earnings per share for Q1 2023 were both ¥0.34, down from ¥0.38 in Q1 2022[21] - Total operating costs for Q1 2023 were ¥128,994,014.63, a decrease of 8.0% from ¥140,328,498.98 in Q1 2022[19] - The company experienced a significant increase in sales expenses, which rose to ¥2,379,033.18 from ¥1,515,806.07 in Q1 2022, marking a 57.0% increase[19] Cash Flow and Assets - The net cash flow from operating activities was ¥5,963,457.17, down 80.90% year-on-year, primarily due to slower revenue growth and higher operational costs[6][9] - Cash flow from operating activities generated a net amount of ¥5,963,457.17, a significant decrease from ¥31,222,767.65 in Q1 2022[21] - The company reported a decrease in cash and cash equivalents, ending Q1 2023 with ¥698,594,593.00, down from ¥753,998,611.55 at the beginning of the quarter[22] - The company's current assets totaled CNY 1,396,521,695.86, down from CNY 1,486,060,742.25, indicating a decrease of about 6.03%[15] - Cash and cash equivalents were reported at CNY 704,909,574.75, a decrease from CNY 754,787,710.49, representing a decline of approximately 6.61%[15] Research and Development - The total R&D investment amounted to ¥16,769,702.82, which is an increase of 34.12% compared to the same period last year[6][10] - R&D investment accounted for 10.35% of operating revenue, up by 3.26 percentage points year-on-year[6] - Research and development expenses increased to ¥16,769,702.82, up 34.1% from ¥12,503,664.17 in Q1 2022[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,973,566,083.26, a decrease of 2.15% from the end of the previous year[6] - The company's non-current assets totaled CNY 577,044,387.40, an increase from CNY 530,888,165.40, indicating an increase of about 8.7%[16] - Total liabilities decreased to CNY 208,007,502.64 from CNY 285,783,871.30, reflecting a reduction of approximately 27.3%[17] - The company's equity attributable to shareholders rose to CNY 1,765,558,580.62 from CNY 1,731,165,036.35, an increase of about 1.98%[17] - The company's total liabilities to equity ratio improved to approximately 0.12 from 0.16, indicating a stronger equity position relative to liabilities[17] Shareholder Information - The company had a total of 5,300 common shareholders at the end of the reporting period[12] - The largest shareholder, Dongguan Dinghong Junsheng Investment Co., Ltd., held 39.58% of the shares[12] Accounting Changes - The company announced the implementation of new accounting standards starting from 2023, affecting the financial statements from the beginning of the year[23]